Overall, while UC IL-6 demonstrates significant potential as an early biomarker for neonatal sepsis, the heterogeneity of reported cut-off values underscores the need for further large-scale, standardized studies to establish clinically reliable thresholds. This evidence concerns the gene IL6 and Sepsis.